• 제목/요약/키워드: 2009 H1N1 influenza

검색결과 75건 처리시간 0.02초

의안(醫案)을 통한 신종 인플루엔자의 한의학적 대처방안 (A Study on Traditional Korean Medical Countermeasures of Influenza A by Case Histories)

  • 안상영;한창현;권오민;박상영;안상우
    • 대한한의학원전학회지
    • /
    • 제22권4호
    • /
    • pp.221-239
    • /
    • 2009
  • Background: The recent outbreak of the novel strain of influenza A (H1N1) virus has raised a global concern of the future risk of pandemic. Traditional Korean Medicine(TKM) has been combatting against contagious diseases and developed its own particular and efficient way in treating those diseases. Objectives: Provide a distinctive and effective TKM method in understanding the principles of treatment, prevention, and contraindications against influenza A through case histories. Method: We revised case histories of eminent doctors of Ming and Qing dynasties according to their clinical manifestations similar to those of influenza A. We also verified prescriptions of the "Dong-uibogam(東醫寶鑑)" through examining clinical practices of China today. Results: 1. The subtypes of Warm disease; Wind Warmth and Pestilence has the most similar clinical manifestation in comparison to Influenza A. Specifying these terms is important in recognizing and classifying various diseases under the name of Warm disease. 2. TKM considered not only external factors but also individual factors like general condition, diet, emotion, constitutional types, etc in the treatment of febrile diseases. 3. TKM developed a new way in the treatment of contagious diseases. considering the characteristics of each pathogen. TKM described the Warm pathogen being light as a feather, which enters through the nose, principally affecting the Lung. Therefore, they emphasized treatment with Pungent Sweet Cooling Moistening[辛甘凉潤] method. 4. As the conservation of fluid and humor is the primordial concern in the treatment of Warm disease, they restricted release of the exterior with pungent-warm and purgation method. The purgation methods was used exclusively to decrease fever and preserve fluid and humor. 5. The only differentiating characteristics of Influenza A with seasonal influenza are vomiting and diarrhea. Case research revealed the possibility of these manifestations to be a mechanism of restoration. 6. TKM provides alimento prevention method like Mint Pear Porridge, mung bean, and etc also combination of herbal medicine. Also emphasized in the conservation of essence for the prevention of contagious diseases. Conclusions: TKM developed its unique way in understanding the pathogenesis, diagnosis, treatment, and prevention of contagious diseases and formed its independent scheme of Warm Disease. This knowledge in febrile contagious disease is relevant today in providing diverse treatment and prevention for influenza A.

  • PDF

성인 호흡곤란 증후군에 있어 체외막 산소화 장치를 이용한 치료 (The Treatment of Adult Respiratory Distress Syndrome (ARDS) Using Extracorporeal Membrane Oxygenation (ECMO))

  • 김고운;최은영;홍상범
    • Tuberculosis and Respiratory Diseases
    • /
    • 제72권1호
    • /
    • pp.1-7
    • /
    • 2012
  • Extracorporeal Membrane Oxygenation (ECMO) support to tissue oxygenation has been shown to improve survival in patients with life threatening respiratory distress syndrome or cardiac failure. Extracorporeal life support such as ECMO, including extracorporeal $CO_2$ removal ($ECCO_2R$), is used as temporary support until successful recovery of organs. A recently published multicentre randomized controlled trial, known as the CESAR (conventional ventilation or extracorporeal membrane oxygenation for severe adult respiratory failure) trial, was the first trial to demonstrate the utility of ECMO in acute respiratory distress syndrome (ARDS). During the 2009 influenza A (H1N1) pandemic, there were many reports of patients with severe ARDS related to H1N1 infection treated with ECMO. These reports revealed a high survival rate and effectiveness of ECMO. In this review, we explain the indication of ECMO clinical application, the practical types of ECMO, and complications associated with ECMO. In addition, we explain recent new ECMO technology and management of patients during ECMO support.

식품의약품안전청 약물유해반응 보고자료 분석 (Analysis of the Korea Food and Drug Administration Adverse Drug Reaction Reports)

  • 유기연;이숙향
    • 한국임상약학회지
    • /
    • 제21권2호
    • /
    • pp.138-144
    • /
    • 2011
  • In order to minimize such adverse drug reactions, governments and international organs have been on the watch for them. Also in South Korea, a system has been established in order that adverse drug reactions may be reported to Korea Food and Drug Administration(KFDA). This study is to analyze drugs to cause adverse reactions, the adverse reactions and patients concerned on the authority of the data of Korea FDA, which is expected to be the preliminary data on preventable adverse reactions. This study was conducted on the 74,037 cases of adverse drug reactions reported to Korea FDA between January 2007 and June 2010. Fentanyl, iopromide and tramadol caused adverse reactions with high frequencies. Oseltamivir showed a high frequency between 2009 and 2010 due to the influence of the new influenza A. Also, OTC drugs accounted for approximately 5% of the adverse reactions. In 2009, adverse drug reactions remarkably increased (2,106 cases; 10.1%) in infants and children due to the new influenza-A(H1N1). The patients aged between 31 and 64 accounted for approximately 55% during the given period. There was no significant intergender difference. In relation to regions, the adverse reactions most frequently occurred in the gastrointestinal system and the integumentary system for three and half years. In addition to anticancer drugs and immunosuppressive drugs that are known to cause adverse reactions frequently, not a few of OTC drugs and external preparations caused such reactions. In particular, the drugs containing specific ingredients caused adverse reactions more frequently than others from 2007 until the first half of 2010. It is advisable for prescribers to acquaint themselves with such adverse reactions and to prescribe drugs other than them. They also have need to sensibly cope with adverse drug reactions just in case they have no substitute drugs. In addition, patients also need to be trained to understand possible adverse reactions in order that they can sensibly accommodate them or choose healthcare services. The results of this study are expected to be helpful to minimize adverse drug reactions.

배양세포에서 Semi-quantitative RT-PCR에 의한 조류인플루엔자 H9N2의 전사활성 분석 최적 시기 결정 및 전사체 분석 (Deterimination of an Optimal Time Point for Analyzing Transcriptional Activity and Analysis of Transcripts of Avian Influenza Virus H9N2 in Cultured Cell)

  • 나기윤;이영민;변승준;전익수;박종현;조인수;주이석;이윤정;권준헌;구용범
    • 미생물학회지
    • /
    • 제45권3호
    • /
    • pp.286-290
    • /
    • 2009
  • 조류인플루엔자 바이러스 mRNA의 전사는 감염 동안에 시간적으로 조절되어진다. 감염 후 세포 내에서 증식된 바이러스가 방출되어 세포를 다시 감염하게 되면 전사 수준 분석에 오차가 발생할 수 있으므로 바이러스가 방출 되기 이전에 전사 수준의 측정이 이루어져야 한다. 본 연구에서는 조류인플루엔자 H9N2를 감염시킨 닭의 섬유아세포주 UMNSAH/DF-1에서 바이러스 감염 후 증식된 바이러스의 방출까지의 시간을 측정하기 위하여 배양액 중에 방출되는 바이러스 RNA 게놈 수준을 semi-quantitative RT-PCR에 의해 측정하였다. 배양액 중의 바이러스 RNA 게놈의 분리 과정에서 발생할 수 있는 RNA 회수율의 오차를 보정하기 위해 mouse의 전체 RNA를 배양액 시료에 넣어서 바이러스 RNA 분리에 carrier로 사용하고 그 속에 포함된 mouse의 GAPDH를 RNA를 역전사 반응 및 PCR의 내부 대조 RNA로 사용하였다. 그 결과 감염 후 방출까지 16~20시간이 소요됨을 알 수 있었다. 따라서 감염 후 12시간 후에 세포 내에서 합성된 8종의 전사체의 수준을 측정하였다. 8종의 mRNA 중 PA를 제외한 7종의 mRNA (HA, NA, PB1, PB2, NP, M, NS를 암호화하는 mRNA)는 뚜렷한 증폭 band를 보였으며, 이것은 이들이 전사활성 측정에 사용될 수 있는 것으로 나타났다. 이상과 같은 전사수준의 측정 방법은 조류인플루엔자 바이러스의 RNA polymerase를 표적으로 한 항바이러스제의 검색에 사용할 수 있을 것으로 보인다.

건강 위험 인식 연구 : 보건학 연구를 위한 함의 (The Study of Health-Risk Perception: Implications for Health Services Research)

  • 유명순
    • 보건행정학회지
    • /
    • 제19권3호
    • /
    • pp.45-70
    • /
    • 2009
  • Outbreaks of health risks such as the Influenza A virus (H1N1) are continuing, which highlights the immediacy of risk control strategies to reduce public's fear and protect the safety of the society. Evidence suggests that success for risk management is basically dependent on the public's willingness to adopt health behaviors recommended by experts, and the behavioral intention relies on their risk perception. Understanding of how individuals think of and feel about health risks is thereby important. This article aims to provide insights for future study on health-risk perception. The main streams and recent developments of theorizing and research on health risk perception are reviewed. The issues, such as (1) health risk perception is an important component for shaping relevant health policies as it reflects public trust of the institutions managing health risks, (2) despite this significance, however, few attempts have been made to address the meaning of 'perceiving health risks' in health services research, are shed light on. On the basis on the critical discussion of the contributions and the limitations of the literature, this article finishes with a few of research agendas by three levels of analysis in risk perception research.